These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 17205568)

  • 1. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood.
    Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ
    Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation.
    Lara O; Tong X; Zborowski M; Chalmers JJ
    Exp Hematol; 2004 Oct; 32(10):891-904. PubMed ID: 15504544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting carcinoma cells in peripheral blood of patients with hepatocellular carcinoma by immunomagnetic beads and rt-PCR.
    Guo J; Yao F; Lou Y; Xu C; Xiao B; Zhou W; Chen J; Hu Y; Liu Z
    J Clin Gastroenterol; 2007 Sep; 41(8):783-8. PubMed ID: 17700428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood.
    Stimpfl M; Schmid BC; Obermair A; Tong D; Schiebel I; Gitsch G; Leodolter S; Zeillinger R
    Oncol Res; 1999; 11(8):367-73. PubMed ID: 10803740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating cancer cells in human oral squamous cell carcinoma.
    Zen H; Nakashiro K; Shintani S; Sumida T; Aramoto T; Hamakawa H
    Int J Oncol; 2003 Sep; 23(3):605-10. PubMed ID: 12888894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription-polymerase chain reaction for epidermal growth factor receptor.
    Leitzel K; Lieu B; Curley E; Smith J; Chinchilli V; Rychlik W; Lipton A
    Clin Cancer Res; 1998 Dec; 4(12):3037-43. PubMed ID: 9865918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
    Huang TH; Wang Z; Li Q; Li FR; Qi H; Zhou HX
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):676-80. PubMed ID: 18246797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells.
    Zieglschmid V; Hollmann C; Gutierrez B; Albert W; Strothoff D; Gross E; Böcher O
    Anticancer Res; 2005; 25(3A):1803-10. PubMed ID: 16033103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.
    Meye A; Bilkenroth U; Schmidt U; Füssel S; Robel K; Melchior AM; Blümke K; Pinkert D; Bartel F; Linne C; Taubert H; Wirth MP
    Int J Oncol; 2002 Sep; 21(3):521-30. PubMed ID: 12168095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse transcriptase-polymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: a sensitive method for monitoring purging efficiency.
    Hildebrandt M; Mapara MY; Körner IJ; Bargou RC; Moldenhauer G; Dörken B
    Exp Hematol; 1997 Jan; 25(1):57-65. PubMed ID: 8989908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction.
    Guo J; Xiao B; Jin Z; Qin L; Chen J; Chen H; Zhang X; Liu Z
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1279-84. PubMed ID: 16048578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.
    Roncella S; Ferro P; Bacigalupo B; Pronzato P; Tognoni A; Falco E; Gianquinto D; Ansaldo V; Dessanti P; Fais F; Rosai J; Fedeli F
    J Exp Clin Cancer Res; 2005 Jun; 24(2):265-71. PubMed ID: 16110760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignancies.
    Brooimans RA; de Leeuw N; Bontenbal M; Gratama JW
    J Biol Regul Homeost Agents; 2005; 19(1-2):84-91. PubMed ID: 16178280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.
    Clarke LE; Leitzel K; Smith J; Ali SM; Lipton A
    Int J Oncol; 2003 Feb; 22(2):425-30. PubMed ID: 12527944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro.
    Zigeuner RE; Riesenberg R; Pohla H; Hofstetter A; Oberneder R
    J Urol; 2003 Feb; 169(2):701-5. PubMed ID: 12544346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method.
    Naume B; Borgen E; Tøssvik S; Pavlak N; Oates D; Nesland JM
    Cytotherapy; 2004; 6(3):244-52. PubMed ID: 15203981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry.
    Allan AL; Vantyghem SA; Tuck AB; Chambers AF; Chin-Yee IH; Keeney M
    Cytometry A; 2005 May; 65(1):4-14. PubMed ID: 15810015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease detection in breast cancer: improved sensitivity using cytokeratin 19 and epidermal growth factor receptor RT-PCR.
    Fellowes VS; Husebekk A; Gress RE; Vance BA
    Int J Oncol; 2004 Apr; 24(4):861-7. PubMed ID: 15010823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction.
    Brakenhoff RH; Stroomer JG; ten Brink C; de Bree R; Weima SM; Snow GB; van Dongen GA
    Clin Cancer Res; 1999 Apr; 5(4):725-32. PubMed ID: 10213205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.